The quality of clinical trials with Harpagophytum procumbens
- 31 December 2003
- journal article
- review article
- Published by Elsevier in Phytomedicine
- Vol. 10 (6-7) , 613-623
- https://doi.org/10.1078/094471103322331647
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A randomized double-blind pilot study comparing Doloteffin(R) and Vioxx(R) in the treatment of low back painRheumatology, 2003
- Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin® in patients with pain in the lower back, knee or hipPhytomedicine, 2002
- Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trialArthritis & Rheumatism, 2001
- Harpagophytum-Extrakt LI 174 (Teufelskralle) bei der Behandlung unspezifischer RückenschmerzenDer Schmerz, 2001
- Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyThe American Journal of Medicine, 2000
- Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritisPhytomedicine, 2000
- Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind studyEuropean Journal of Anaesthesiology, 1999
- Wirksamkeit und Wirtschaftlichkeit von Teufelskrallenwurzelextrakt bei Rückenschmerzen: Erste Ergebnisse einer therapeutischen KohortenstudieComplementary Medicine Research, 1997
- Effectiveness of Harpagophytum procumbens in treatment of acute low back painPhytomedicine, 1996
- The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hipArthritis & Rheumatism, 1991